Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Victor Poirier"'
Autor:
Richard Berman, Robert Byrne, DeanF. Martin, JamesJ. Wynne, Victor Poirier, LyleH. Schwartz, Selim Chacour, David Eddy, Paul R. Sanberg, William Cavanaugh
Publikováno v:
Technology & Innovation. 18:319-330
Autor:
Satoshi Furukawa, Alfred J. Tector, Walter P. Dembitsky, Laura Damme, Gerald Heatley, Nuala S. Ronan, Alan D. Weinberg, William Piccione, James W. Long, Annetine C. Gelijns, Soon J. Park, William L. Holman, Victor Poirier, Alan J. Moskowitz
Publikováno v:
The Annals of Thoracic Surgery. 78:2123-2130
Background Left ventricular assist device (LVAD) failure and malfunction rates are critical gauges for establishing LVADs as a long-term therapy for end-stage heart failure patients. These device performance measures, however, have been inadequately
Autor:
Edward Hampton, Victor Poirier, Reto Schöb, David J. Farrar, Kevin Bourque, Z. Jon Wu, Howard M. Loree, Thomas Gempp, Greg W. Burgreen, Charles Dague
Publikováno v:
Artificial Organs. 28:874-880
The fluid dynamics of the Thoratec HeartMate III (Thoratec Corp., Pleasanton, CA, U.S.A.) left ventricular assist device are analyzed over a range of physiological operating conditions. The HeartMate III is a centrifugal flow pump with a magnetically
Autor:
O.H. Frazier, Yoshifumi Naka, T.B. Icenogle, Victor Poirier, Robert D. Dowling, Soon J. Park, Francis D. Pagani, Alfred J. Tector
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 25:958-963
Objective: The HeartMate® VE left ventricular assist system (LVAS) has supported more than 2300 patients and has been shown to be effective for bridge to cardiac transplantation and has demonstrated improved outcomes in survival as a destination the
Autor:
Victor Poirier, Andreas Fleischli, Giampiero Foiera, J. Scott Richardson, R. Schoeb, Thomas Gempp, D. Gernes, Kevin Bourque, Howard M. Loree, Natale Barletta
Publikováno v:
Artificial Organs. 26:939-942
The promise of expanded indications for left ventricular assist devices in the future for very long-term applications (10+ years) prompts sealed (i.e. fully implanted) systems and less-obtrusive and more reliable implanted components than their exter
The HeartMate III: Design and In Vivo Studies of a Maglev Centrifugal Left Ventricular Assist Device
Autor:
Mary J. Watach, R. Schoeb, Andreas Fleischli, P. Litwak, Natale Barletta, Thomas Gempp, G. Foiera, Victor Poirier, Kevin Bourque, Takehide Akimoto, D. Gernes, Marina V. Kameneva, J. S. Richardson, Howard M. Loree, Kenneth N. Litwak
Publikováno v:
Artificial Organs. 25:386-391
A compact implantable centrifugal left ventricular assist device (LVAD) (HeartMate III) featuring a magnetically levitated impeller is under development. The goal of our ongoing work is to demonstrate feasibility, low hemolysis, and low thrombogenici
The HeartMate II: Design and Development of a Fully Sealed Axial Flow Left Ventricular Assist System
Autor:
Douglas C. Thomas, Victor Poirier, Kenneth Butler, David J. Burke, Timothy R. Maher, Edward Burke, Farzad Parsaie, Lynn P. Taylor
Publikováno v:
Artificial Organs. 25:380-385
Our group is developing the control and power transmission components required to implement a permanent and fully sealed left ventricular assist system (LVAS). Starting with the percutaneously powered HeartMate II blood pump, our development efforts
Autor:
Victor Poirier
Publikováno v:
Artificial Organs. 20:475-480
Active U.S. participation in the development of artificial heart technology began in 1966 with the award of six contracts. Since that beginning, and continuing to this day, we have been asking the same question, "Can we develop a system to take the p
Publikováno v:
IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in MedicineBiology Society. 5(1)
Autor:
Victor Poirier, D.B. Dyke, Francis D. Pagani, Jonathan W. Haft, Yoshi Suzuki, Susan Wright, Keith D. Aaronson
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 53(3)
Predicting end-of-life for left ventricular assist devices is important to determine timing of device removal. A retrospective analysis was performed on 46 patients undergoing implantation of the latest HeartMate XVE from July 1, 2003, through March